Misplaced Pages

Endralazine

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Chemical compound Pharmaceutical compound
Endralazine
Clinical data
ATC code
Identifiers
IUPAC name
  • 6-benzoyl-3-hydrazinyl-5H,6H,7H,8H-pyridopyridazine
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H15N5O
Molar mass269.308 gยทmol
3D model (JSmol)
SMILES
  • c1ccc(cc1)C(=O)N2CCc3c(c/c(=N/N)/n3)C2
InChI
  • InChI=1S/C14H15N5O/c15-16-13-8-11-9-19(7-6-12(11)17-18-13)14(20)10-4-2-1-3-5-10/h1-5,8H,6-7,9,15H2,(H,16,18)
  • Key:ALAXZYHFVBSJKZ-UHFFFAOYSA-N
  (what is this?)  (verify)

Endralazine is an antihypertensive of the hydrazinophthalazine chemical class. It is not approved for use in the United States.

References

  1. Meredith PA, Elliott HL, McSharry DR, Kelman AW, Reid JL (July 1983). "The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjects". British Journal of Clinical Pharmacology. 16 (1): 27โ€“32. doi:10.1111/j.1365-2125.1983.tb02139.x. PMC 1427948. PMID 6882620.
Nonsympatholytic vasodilatory antihypertensives (C02)
Nitrovasodilator (arterioles and venules)
Hydrazinophthalazines (arterioles)
Potassium channel openers (arterioles)
Calcium channel blockers (arterioles)
Hydrazines
Stub icon

This antihypertensive-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: